FDA Inspection 1112681 — Biohaven Pharmaceuticals, Inc
The FDA completed an inspection of Biohaven Pharmaceuticals, Inc on November 7, 2019 in New Haven, CT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 7, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New Haven, CT (United States)
Additional Details
Sponsor, Contract Research Organization